(UroToday.com) The 2026 GU ASCO annual meeting featured an innovations in kidney cancer in 2026 session and a presentation by Dr. Michael Hofman discussing emerging tools in imaging in renal cell ...
(UroToday.com) The 2025 SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Benjamin Garmezy discussing a phase 1 trial of mevrometostat (PF-06821497), a potent and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results